Published in Lancet on November 16, 1996
Lack of evidence for hepatitis G virus replication in the livers of patients coinfected with hepatitis C and G viruses. J Virol (1997) 1.26
In vitro infection of human peripheral blood mononuclear cells by GB virus C/Hepatitis G virus. J Virol (1999) 1.09
Detection of hepatitis B virus infection in wild-born chimpanzees (Pan troglodytes verus): phylogenetic relationships with human and other primate genotypes. J Virol (2000) 1.08
Faster HIV-1 disease progression among Brazilian individuals recently infected with CXCR4-utilizing strains. PLoS One (2012) 1.05
Detection of hepatitis G virus replication sites by using highly strand-specific Tth-based reverse transcriptase PCR. J Virol (1998) 1.01
Role of GB virus C in modulating HIV disease. Expert Rev Anti Infect Ther (2012) 0.95
A high frequency of GBV-C/HGV coinfection in hepatitis C patients in Germany. World J Gastroenterol (2000) 0.93
Hepatitis G virus infection in chronic liver disease. Gut (1998) 0.90
Hepatitis G virus. World J Gastroenterol (2008) 0.89
GB virus C/hepatitis G virus (GBV-C/HGV): still looking for a disease. Int J Exp Pathol (2000) 0.88
Prevalence, incidence density, and genotype distribution of GB virus C infection in a cohort of recently HIV-1-infected subjects in Sao Paulo, Brazil. PLoS One (2011) 0.85
TT viral infection through blood transfusion: retrospective investigation on patients in a prospective study of post-transfusion hepatitis. World J Gastroenterol (2000) 0.82
Hepatitis G virus infection in fulminant hepatic failure. Gut (1997) 0.81
Frequency and genotypic distribution of GB virus C (GBV-C) among Colombian population with Hepatitis B (HBV) or Hepatitis C (HCV) infection. Virol J (2011) 0.81
Intravitreal human immune globulin in a rabbit model of Staphylococcus aureus toxin-mediated endophthalmitis: a potential adjunct in the treatment of endophthalmitis. Trans Am Ophthalmol Soc (2004) 0.80
Interactions Between GB Virus Type C and HIV. Curr Infect Dis Rep (2002) 0.79
Age-dependent acquisition of hepatitis G virus/GB virus C in a nonrisk population: detection of the virus by antibodies. J Clin Microbiol (1999) 0.78
Co-infections and transmission networks of HCV, HIV-1 and HPgV among people who inject drugs. Sci Rep (2015) 0.77
Hepatitis G virus infection in lymphoma and in blood donors. J Clin Pathol (1998) 0.77
Comparison of six sets of PCR primers from two different genomic regions for amplification of GB virus C/hepatitis G virus RNA. J Clin Microbiol (1998) 0.77
Role of GB virus C in HIV-1-infected and hepatitis C virus-infected hemophiliac children and adolescents. J Acquir Immune Defic Syndr (2012) 0.77
Infection with hepatitis G virus in immunoglobulin recipients. Lancet (1997) 0.75
Infection with hepatitis G virus in immunoglobulin recipients. Lancet (1997) 0.75
GB virus C/hepatitis G virus infection in HIV infected patients with haemophilia despite treatment with virus inactivated clotting factor concentrates. Arch Dis Child (1999) 0.75
Infection with hepatitis G virus in immunoglobulin recipients. Lancet (1997) 0.75
Hepatitis G virus infection among liver graft recipients: anatomoclinical correlations. Dig Dis Sci (1998) 0.75
Porphyria cutanea tarda and hepatitis G and C virus infection. Eur J Clin Microbiol Infect Dis (1998) 0.75
Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol (1993) 8.07
Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers. J Virol (1990) 6.73
Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection. J Virol (1993) 6.41
Analysis of sequence diversity in hypervariable regions of the external glycoprotein of human immunodeficiency virus type 1. J Virol (1990) 5.20
Guidelines for the management of hemophilia. Haemophilia (2012) 5.16
Detection of a novel DNA virus (TTV) in blood donors and blood products. Lancet (1998) 5.15
Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet (1996) 4.05
A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology (1994) 4.01
Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. International Committee on Virus Taxonomy. Arch Virol (1998) 3.77
Managing patients with lung cancer. New guidelines should improve standards of care. BMJ (1999) 3.65
Convergent and divergent sequence evolution in the surface envelope glycoprotein of human immunodeficiency virus type 1 within a single infected patient. Proc Natl Acad Sci U S A (1992) 3.58
Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J Gen Virol (1992) 3.37
HCV confirmatory testing of blood donors. Lancet (1991) 3.29
Testing of blood donations for hepatitis C virus. Lancet (1994) 3.27
Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5' non-coding region. J Gen Virol (1995) 3.10
Epidemiological profile and clinical associations of human bocavirus and other human parvoviruses. J Infect Dis (2006) 2.97
Variation of the hepatitis C virus 5' non-coding region: implications for secondary structure, virus detection and typing. The International HCV Collaborative Study Group. J Gen Virol (1995) 2.91
Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J Clin Microbiol (1994) 2.90
Sequence variability in the 5' non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity. J Gen Virol (1993) 2.87
Concurrent evolution of human immunodeficiency virus type 1 in patients infected from the same source: rate of sequence change and low frequency of inactivating mutations. J Virol (1990) 2.68
Identification of shared populations of human immunodeficiency virus type 1 infecting microglia and tissue macrophages outside the central nervous system. J Virol (2001) 2.62
Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology (1994) 2.60
Identification of genotypes of hepatitis C virus by sequence comparisons in the core, E1 and NS-5 regions. J Gen Virol (1994) 2.53
Outbreak of acute hepatitis C following the use of anti-hepatitis C virus--screened intravenous immunoglobulin therapy. Gastroenterology (1996) 2.48
Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infection. Gut (1998) 2.45
Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3. J Clin Microbiol (1993) 2.36
The origin of hepatitis C virus genotypes. J Gen Virol (1997) 2.26
Detection of three types of hepatitis C virus in blood donors: investigation of type-specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities. Transfusion (1993) 2.24
A highly divergent picornavirus in a marine mammal. J Virol (2007) 2.23
Frequent infection of peripheral blood CD8-positive T-lymphocytes with HIV-1. Edinburgh Heterosexual Transmission Study Group. Lancet (1996) 2.20
Factor VIII inhibitors in mild and moderate-severity haemophilia A. UK Haemophilia Centre Directors Organisation. Thromb Haemost (1998) 2.20
Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer. J Clin Oncol (1999) 2.19
The end of the heparin pump? Low molecular weight heparin has many advantages over unfractionated heparin. BMJ (1998) 2.13
Complete nucleotide sequence of a type 4 hepatitis C virus variant, the predominant genotype in the Middle East. J Gen Virol (1997) 2.13
Recurrent genital candidosis in women and the effect of intermittent prophylactic treatment. Br J Vener Dis (1978) 2.12
Human T-lymphotropic virus type III (HTLV-III) infection in seronegative haemophiliacs after transfusion of factor VIII. Lancet (1985) 2.08
Virus 'quasispecies': making a mountain out of a molehill? J Gen Virol (1997) 2.07
HTLV-III antibody in Edinburgh drug addicts. Lancet (1985) 2.03
Hepatitis C quantification and sequencing in blood products, haemophiliacs, and drug users. Lancet (1990) 2.01
Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification. The International HCV Collaborative Study Group. J Gen Virol (1995) 2.00
Influence of HAART on HIV-related CNS disease and neuroinflammation. J Neuropathol Exp Neurol (2005) 1.98
No evidence for an association between infections with WU and KI polyomaviruses and respiratory disease. J Clin Virol (2007) 1.96
New-variant Creutzfeldt-Jakob disease and treatment of haemophilia. Executive Committee of the UKHCDO. United Kingdom Haemophilia Centre Directors' Organisation. Lancet (1997) 1.94
The molecular epidemiology of human immunodeficiency virus type 1 in Edinburgh. J Infect Dis (1995) 1.94
Detection, quantification and sequencing of HIV-1 from the plasma of seropositive individuals and from factor VIII concentrates. AIDS (1991) 1.93
Association of HLA types A1-B8-DR3 and B27 with rapid and slow progression of HIV disease. QJM (1996) 1.88
Characteristics of nucleotide substitution in the hepatitis C virus genome: constraints on sequence change in coding regions at both ends of the genome. J Mol Evol (1997) 1.88
Early increase in levels of soluble inter-cellular adhesion molecule-1 (sICAM-1); potential risk factor for the acute coronary syndromes. Eur Heart J (2001) 1.87
Transmission of non-A, non-B hepatitis by pH4-treated intravenous immunoglobulin. Vox Sang (1989) 1.85
Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: a mechanism for arterial thrombosis and myocardial infarction. Circulation (1999) 1.79
Interleukin 6 and haemostasis. Br J Haematol (2001) 1.75
Serological responses to infection with three different types of hepatitis C virus. Lancet (1991) 1.73
Acquired haemophilia and its management. Br J Haematol (1995) 1.69
Epidemiology and clinical associations of human parechovirus respiratory infections. J Clin Microbiol (2008) 1.68
Confirmation of hepatitis C virus antibody in blood donors. J Med Virol (1993) 1.68
Genotype dependence of hepatitis C virus load measurement in commercially available quantitative assays. J Clin Microbiol (1999) 1.68
Treatment for haemophilia by postcode. BMJ (1997) 1.67
Heterosexual transmission of hepatitis C virus. Lancet (1993) 1.65
HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS. Effect of neocortical involvement. Brain (1998) 1.65
Familial breast cancer: an investigation into the outcome of treatment for early stage disease. Fam Cancer (2001) 1.62
Detailed mapping of RNA secondary structures in core and NS5B-encoding region sequences of hepatitis C virus by RNase cleavage and novel bioinformatic prediction methods. J Gen Virol (2004) 1.62
Mechanism of promoter selection by RNA polymerase II: mammalian transcription factors alpha and beta gamma promote entry of polymerase into the preinitiation complex. Proc Natl Acad Sci U S A (1991) 1.62
HIV-1 tropism and co-receptor use. Nature (1997) 1.60
Determinants of HIV disease progression: six-year longitudinal study in the Edinburgh haemophilia/HIV cohort. Lancet (1991) 1.58
Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States. Hepatitis Interventional Therapy Group. Ann Intern Med (1996) 1.56
Hepatitis C virus (HCV) genotypes and chronic liver disease in Pakistan. J Gastroenterol Hepatol (1997) 1.55
First coitus before menarche and risk of sexually transmitted disease. Lancet (1990) 1.55
Molecular investigation of human immunodeficiency virus (HIV) infection in a patient of an HIV-infected surgeon. J Infect Dis (1993) 1.54
Molecular epidemiology of an outbreak of infection with hepatitis C virus in recipients of anti-D immunoglobulin. Lancet (1995) 1.54
Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method. J Clin Microbiol (2010) 1.54
Sodium intake and blood pressure in two Polynesian populations. N Engl J Med (1968) 1.54
Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann Intern Med (1995) 1.53
Lipodystrophy associated with nevirapine-containing antiretroviral therapies. AIDS (1999) 1.52
Prevalence and epidemiological characteristics of hepatitis C in Scottish blood donors. Transfus Med (1994) 1.51
Specific association of human parechovirus type 3 with sepsis and fever in young infants, as identified by direct typing of cerebrospinal fluid samples. J Infect Dis (2009) 1.50